Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel

M Silferi, A Mauri, P Deiana, A Grasso… - European Journal of …, 1994 - Elsevier
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40 25 μg+ 15 days 30 125 μg) was tested for its reliability …
被引用次数：19 相关文章

[引用][C] Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel

A VOLPE, M SILFERI, A MAURI… - European journal of …, 1994 - pascal-francis.inist.fr
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation
containing desogestrel CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel

A Volpe, M Silferi, A Mauri, P Deiana… - European journal …, 1994 - pubmed.ncbi.nlm.nih.gov
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40/25 micrograms+ 15 days 30/125 micrograms) was …

Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.

A Volpe, M Silferi, A Mauri, P Deiana… - EUROPEAN JOURNAL …, 1994 - arpi.unipi.it
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40/25 micrograms+ 15 days 30/125 micrograms) was …

EFFICACY ON HYPERANDROGENISM AND SAFETY OF A NEW ORAL-CONTRACEPTIVE BIPHASIC FORMULATION CONTAINING DESOGESTREL

A Volpe, M Silferi, A Mauri, P Deiana… - EUROPEAN …, 1994 - iris.unimore.it
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40/25 mug+ 15 days 30/125 mug) was tested for its …

[引用][C] Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.

A Volpe, M Silferi, A Mauri, P Deiana… - EUROPEAN JOURNAL …, 1994 - iris.unica.it
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation
containing desogestrel. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.

A Volpe, M Silferi, A Mauri, P Deiana… - European Journal of …, 1994 - europepmc.org
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40/25 micrograms+ 15 days 30/125 micrograms) was …

Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel

A Volpe, M Silferi, A Mauri, P Deiana, S Angioni… - European Journal of …, 1994 - ejog.org
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 4025 μg+ 15 days 30125 μg) was tested for its reliability …

EFFICACY ON HYPERANDROGENISM AND SAFETY OF A NEW ORAL-CONTRACEPTIVE BIPHASIC FORMULATION CONTAINING DESOGESTREL

A Volpe, M Silferi, A Mauri, P Deiana… - EUROPEAN …, 1994 - iris.unimore.it
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40/25 mug+ 15 days 30/125 mug) was tested for its …

[引用][C] Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel

A VOLPE, M SILFERI, A MAURI, P DEIANA… - European journal of …, 1994 - Elsevier